Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 28;18(7):e0288875.
doi: 10.1371/journal.pone.0288875. eCollection 2023.

Psychosocial impact at the time of a rare disease diagnosis

Juan Benito-Lozano  1   2 , Greta Arias-Merino  1 , Mario Gómez-Martínez  1 , Beatriz Arconada-López  3 , Begoña Ruiz-García  4 , Manuel Posada de la Paz  1   5 , Verónica Alonso-Ferreira  1   6
Affiliations

Psychosocial impact at the time of a rare disease diagnosis

Juan Benito-Lozano et al. PLoS One. .

Abstract

Over half of all persons with rare diseases (RDs) in Spain experience diagnostic delay (DD) but little is known about its consequences. This study therefore aimed to analyze the psychological impact of obtaining a diagnosis of an RD, and to ascertain what social determinants are influenced and what the personal consequences are, according to whether or not patients experienced DD. Data were obtained from a purpose-designed form completed by persons registered at the Spanish Rare Diseases Patient Registry. The following were performed: a descriptive analysis; a principal component analysis (PCA); and logistic regressions. Results revealed that while searching for a diagnosis, people who experienced DD were more in need of psychological care than those diagnosed in less than one year (36.2% vs 23.2%; p = 0.002; n = 524). The PCA identified three principal components, i.e., psychological effects, social implications, and functional impact. Reducing DD would improve psychological effects, such as irritability (OR 3.6; 95%CI 1.5-8.5), frustration (OR 3.4; 95%CI 1.7-7.1) and concentration on everyday life (OR 3.3; 95%CI 1.4-7.7). The influence of the social implications and functional repercussions of the disease was greater in persons with DD (scores of 22.4 vs 20 and 10.6 vs 9.4, respectively) in terms of the difficulty in explaining symptoms to close friends and family (3.3 vs 2.9), and loss of independence (3.3 vs 2.9). In conclusion, this is the first study to analyze the psychosocial impact of diagnosis of RDs in Spain and one of few to assess it in the patients themselves, based on data drawn from a purpose-designed form from a national registry open to any RD. People affected by RDs who underwent DD experienced greater psychosocial impact than did those who were diagnosed within the space of one year.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Principal component analysis (PCA) of psychological impact of diagnostic delay on people affected by RDs.
Fig 2
Fig 2. Social implications (sum of component 2) and functional impact (sum of component 3) on persons with diagnostic delay versus those diagnosed within a year.
Mean is represented in squares and CI in bars.
Fig 3
Fig 3. Social implications variables (component 2) on persons with diagnostic delay versus those diagnosed within a year.
Mean is represented in squares and CI in bars.
Fig 4
Fig 4. Functional repercussions of the disease variables (component 3) on persons with diagnostic delay versus those diagnosed within a year.
Mean is represented in squares and CI in bars.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Decision No 1295/1999/EC of the European Parliament and of the Council of 29 April 1999 adopting a programme of Community action on rare diseases within the framework for action in the field of public health (1999 to 2003). Available from: http://europa.eu.int/eur-lex/pri/en/oj/dat/1999/l_155/l_15519990622en000...
    1. Valdez R, Ouyang L, Bolen J. Public Health and Rare Diseases: Oxymoron No More. Prev Chronic Dis. 2016;13: E05. Erratum in: Prev Chronic Dis. 2016;13: E20. doi: 10.5888/pcd13.150491 - DOI - PMC - PubMed
    1. Zanello G, Chan CH, Pearce DA; IRDiRC Working Group. Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patients. Orphanet J Rare Dis. 2022;17(1): 181. doi: 10.1186/s13023-022-02337-2 - DOI - PMC - PubMed
    1. Esquivel-Sada D, Thu Nguyen M. Diagnosis of rare diseases under focus: impacts for Canadian patients. J Community Genet. 2018;9: 37–50. doi: 10.1007/s12687-017-0320-x - DOI - PMC - PubMed
    1. van der Kloot WA, Hamdy NA, Hafkemeijer LC, den Dulk FM, Chotkan SA, van Emmerik AA, et al.. The psychological burden of an initially unexplained illness: patients with sternocostoclavicular hyperostosis before and after delayed diagnosis. Health Qual Life Outcomes. 2010;9: 8–97. doi: 10.1186/1477-7525-8-97 - DOI - PMC - PubMed

Publication types